NCT06687837: Treating Parkinson's Disease Through Transplantation of Autologous Stem Cell-Derived Dopaminergic Neurons
- State
- Under way
- Phase
- Phase 1
- People
- 8 planned
- Started
- 29 Apr 2025
- Primary completion
- Dec 2027
- Arms
- Low dose administration, High dose administration
- Results
- None posted
- 14 Nov 2024: Trial registered
- 29 Apr 2025: Trial started